The PMS/AIF AMC Rating is derived on the basis of our analysis on 5 key qualitative parameters that we use to analyse the quality of a PMS/AIF Provider. These include an assessment of the size of the AMC, the pedigree of the AMC, the pedigree of the team, the value of the investment philosophy & the level of differentiation. These insights of our central research team are documented in the IME RMS, and can be accessed during a consultation call with an IME PMS specialist.
AMC Background
Piper Serica has been operating for over 15 years, initially focusing on advisory services such as cross-border M&A and managing personal investments. In 2017, they obtained an RIA license and in March 2019, they received their PMS license. The PMS service is still new and we recommend waiting for it to grow and prove its quality.
Investment Philosophy
Piper Serica invests in sector leaders in growing industries, using a rigorous research process to ensure sustained leadership positions.
Investment Team
Abhay Agarwal | 4-star rated FM
MD & CIO | 32 yrs Experience | 22 yrs at current firm
Past Experience: Director (JP Morgan Partners, Singapore), AVP (Citibank India)
Abhay Agarwal is an experienced CIO (with past experience as Director at JP Morgan PE Asia), as seen with his long-standing association with Piper Serica Advisors. His experience across market cycles is valuable to Piper Serica’s top-down approach to investing in their strategies.
PMS & Listed Equity AIF Schemes
Free 30-Day Trial of the IME RMS
Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).
The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.
Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.